Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is a strong performer in the healthcare industry, driven by its diversification and effective management, specifically in its Optum business and vertical integration strategy. Its recent earnings report showcased successful initiatives, including reduced utilization and improved margins, but the company continues to face challenges in the commercial sector and regulatory concerns. While UNH remains cautiously optimistic about its long-term growth potential, risks to its rating and price target should be considered.

Bears say

UnitedHealth Group is facing significant challenges in its commercial business due to rising costs and aggressive billing practices, leading to delays in settling claims and inappropriately high rates. This has caused the company's margin recovery to be delayed past 2027. Additionally, while management is investing in AI to monitor and understand healthcare costs in real time, it is not yet reflected in the company's financials. As a result, the financial analyst views the company's stock negatively, as they do not believe current market expectations reflect these challenges and potential headwinds.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.